Comment on: Toxicity profile of high-dose methotrexate in young children with central nervous system tumors

被引：0
|
作者：
Cohen, Ian J. [1 ,2 ]
机构：
[1] Schneider Childrens Med Ctr Israel, Rina Zaizov Dept Pediat Hematol Oncol, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel
来源：
PEDIATRIC BLOOD & CANCER | 2024年
关键词：
D O I：
10.1002/pbc.31270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Renal toxicity of high-dose methotrexate
    Garcia, Hugo
    Leblond, Veronique
    Goldwasser, Francois
    Bouscary, Didier
    Raffoux, Emmanuel
    Boissel, Nicolas
    Broutin, Sophie
    Joly, Dominique
    NEPHROLOGIE & THERAPEUTIQUE, 2018, 14 : S103 - S113
  • [42] Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
    Bergner, Nicole
    Monsef, Ina
    Illerhaus, Gerald
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [43] High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system
    Curry, Richard C.
    Faivre, Geraldine
    Akkari, Leila
    Joyce, Johanna A.
    Lin, Oscar
    Rosenblum, Marc
    Diamond, Eli L.
    Fisher, Rebecca
    Omuro, Antonio
    LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1961 - 1964
  • [44] High-dose methotrexate for elderly patients with newly diagnosed primary central nervous system lymphoma
    Zhu, J
    Mrugala, M
    Nugent, W
    Hochberg, F
    Batchelor, T
    ANNALS OF ONCOLOGY, 2005, 16 : 124 - 124
  • [45] Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
    F. Bazan
    E. Dobi
    B. Royer
    E. Curtit
    L. Mansi
    N. Menneveau
    M. J. Paillard
    G. Meynard
    C. Villanueva
    X. Pivot
    L. Chaigneau
    BMC Cancer, 19
  • [46] Isolated Central Nervous System Posttransplant Lymphoproliferative Disorder Treated with High-Dose Intravenous Methotrexate
    Nabors, L. B.
    Palmer, C. A.
    Julian, B. A.
    Przekwas, A. M.
    Kew, C. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) : 1243 - 1248
  • [47] Stereotactic radiosurgery in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma
    Long, H.
    ANNALS OF ONCOLOGY, 2017, 28 : 36 - 36
  • [48] Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma
    Bernard, S.
    Hachon, L.
    Diasonama, J. F.
    Madaoui, C.
    Aguinaga, L.
    Miekoutima, E.
    Moatti, H.
    Perrial, Emeline
    Madelaine, I.
    Brice, P.
    Thieblemont, Catherine
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 979 - 986
  • [49] Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma
    Joerger, M.
    Huitema, A. D. R.
    Illerhaus, G.
    Ferreri, A. J. M.
    LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 1867 - 1875
  • [50] Limited efficacy of high-dose methotrexate to prevent the central nervous system relapse in patients with IVLBCL
    Terao, Toshiki
    Tsushima, Takafumi
    Ikeda, Daisuke
    Fukumoto, Ami
    Kamura, Yuya
    Kuzume, Ayumi
    Tabata, Rikako
    Miura, Daisuke
    Narita, Kentaro
    Takeuchi, Masami
    Matsue, Kosei
    LEUKEMIA & LYMPHOMA, 2022, 63 (14) : 3394 - 3401
12345